🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Hypothesis: 3,4-Diaminopyridine base (3,4-DAP) improves Lambert-Eaton Myast...
Status
Completed
Location
University of California at Davis
Start Date
2012-01
Trial ID
NCT01511978
Treatments Being Tested
This randomized, double-blind, controlled, outpatient two-period, two-treat...
Status
Completed
Location
UCLA Department of Neurology
Start Date
2016-01
Trial ID
NCT02562066
Treatments Being Tested
Primary: The primary objective of this study under the original protocol w...
Status
Approved For Marketing
Location
UCLA
Start Date
TBD
Trial ID
NCT02189720
Treatments Being Tested
A new drug called 3,4-Diaminopyridine (3,4-DAP) is currently under investig...
Status
No Longer Available
Location
University of California, Davis
Start Date
TBD
Trial ID
NCT00704925
Treatments Being Tested
A two-period, two-treatment, crossover study to evaluate the safety, tolera...
Status
Completed
Location
Neurological Institute Carlo Besta
Start Date
2019-01-21
Trial ID
NCT03781479
Treatments Being Tested
if amifampridine can improve neuromuscular transmission in muscles previous...
Status
Completed
Location
Wake Forest University Health Sciences
Start Date
2023-09-15
Trial ID
NCT05769478
Treatments Being Tested
A long term safety study of amifampridine phosphate in patients with spinal...
Status
Terminated
Location
Neurological Institute Carlo Besta
Start Date
2019-03-07
Trial ID
NCT03819660
Treatments Being Tested
A Phase 3 study to evaluate the efficacy and safety of Amifampridine Phosph...
Status
Completed
Location
Multiple Locations
Start Date
2011-06
Trial ID
NCT01377922
Treatments Being Tested
This study evaluates the effect of withdrawing amifampridine phosphate trea...
Status
Completed
Location
UCLA
Start Date
2016-11
Trial ID
NCT02970162
Treatments Being Tested
Efficacy and safety of amifampridine phosphate in improving the activities ...
Status
Completed
Location
Cleveland Clinic
Start Date
2018-04-18
Trial ID
NCT03304054
Treatments Being Tested